Further evidence for an early involvement of p300/CBP in nonviral cancers can be observed in the increased predisposition to childhood malignancies in Rubinstein–Taybi syndrome, which is characterised by germline mutation of CBP as well as numerous somatic mutations in colorectal, breast and gastric carcinomas (Iyer et al, 2004). This evidence concerns the gene EP300 and cancer.